(BUSINESS WIRE)--Pfizer Inc invites investors, media and the general public to view and listen to a webcast of a conference call with investment analysts at 1:00 p.m. EDT on Friday, June 12, 2009. The purpose of the call is to review Phase 2 data for CP-690,550, Pfizer’s oral JAK-3 inhibitor, that will be presented during the Annual Congress of the European League Against Rheumatism (EULAR).

To view and listen to the webcast, visit our web site homepage at www.pfizer.com and click on the “Pfizer Conference Call with Analysts at EULAR” link in the Investor Presentations tab. Information on accessing and pre-registering for the webcast will be available at www.pfizer.com beginning today. Participants are advised to pre-register in advance of the conference call.

You can also listen to the conference call by dialing either (877) 888-4913 in the United States or (513) 618-5002 outside of the United States. The password is “EULAR Webcast”.

Visitors will be able to view and listen to an archived copy of the webcast at www.pfizer.com.